Overview
Nur Farhanah practices practicing medicine in Semarang, Indonesia.
Their clinical expertise encompasses Reticulohistiocytoma and Histiocytosis.
They are actively involved in clinical research, co-authoring 10 peer reviewed articles and participating in 2 clinical trials.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
2 Clinical Trials
Frequently Asked Questions about Nur Farhanah
Is Nur Farhanah a top-rated expert for Reticulohistiocytoma?
MediFind is an objective health platform that identifies experts based on real-world data. Nur Farhanah is classified as an Experienced expert for Reticulohistiocytoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Nur Farhanah participate in research or clinical trials?
Yes. Nur Farhanah has published 10 articles and abstracts on conditions like Reticulohistiocytoma. You can view a list of Nur Farhanah's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- HistiocytosisFarhanah isExperienced. Learn about Histiocytosis.
- ReticulohistiocytomaFarhanah isExperienced. Learn about Reticulohistiocytoma.